Study of TP-04 in Participants With Papulopustular Rosacea
Clinical trial NCT05838170 · COMPLETED
Trial details
- NCT number
- NCT05838170
- Sponsor
- Tarsus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2023-11-13
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.